UCLA NeuroTranslational Research Center — Los Angeles, California

UCLA NeuroTranslational Research Center is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA NeuroTranslational Research Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Parkinsons Disease (PD), Prevention of Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke.

Sponsors: BlueRock Therapeutics, Bayer.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA NeuroTranslational Research Center?

UCLA NeuroTranslational Research Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA NeuroTranslational Research Center conducted?

UCLA NeuroTranslational Research Center has 2 clinical trials on record, with 1 currently active. Their work covers Parkinsons Disease (PD), Prevention of Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke.

Is UCLA NeuroTranslational Research Center accredited by Crixeo Health?

UCLA NeuroTranslational Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA NeuroTranslational Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.